These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 29440769)

  • 21. CUEDC1 inhibits epithelial-mesenchymal transition via the TβRI/Smad signaling pathway and suppresses tumor progression in non-small cell lung cancer.
    Cui Y; Song Y; Yan S; Cao M; Huang J; Jia D; Liu Y; Zhang S; Fan W; Cai L; Li C; Xing Y
    Aging (Albany NY); 2020 Oct; 12(20):20047-20068. PubMed ID: 33099540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduction of metastatic potential by inhibiting EGFR/Akt/p38/ERK signaling pathway and epithelial-mesenchymal transition after carbon ion exposure is potentiated by PARP-1 inhibition in non-small-cell lung cancer.
    Chowdhury P; Dey P; Ghosh S; Sarma A; Ghosh U
    BMC Cancer; 2019 Aug; 19(1):829. PubMed ID: 31438892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Krüppel-Like Factor 8 Overexpression Correlates with Poor Prognosis in Non-Small Cell Lung Cancer.
    Li J; Liu Y; Xue J; Xu M; Zhang J; Liu J; Wang W
    Pathol Oncol Res; 2019 Jan; 25(1):115-121. PubMed ID: 28986741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intratumoral macrophages contribute to epithelial-mesenchymal transition in solid tumors.
    Bonde AK; Tischler V; Kumar S; Soltermann A; Schwendener RA
    BMC Cancer; 2012 Jan; 12():35. PubMed ID: 22273460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic characterization of immune molecular subtypes in non-small cell lung cancer to immunotherapy.
    Li C; Pan J; Luo J; Chen X
    BMC Pulm Med; 2021 Nov; 21(1):389. PubMed ID: 34844602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MiR-145 and miR-203 represses TGF-β-induced epithelial-mesenchymal transition and invasion by inhibiting SMAD3 in non-small cell lung cancer cells.
    Hu H; Xu Z; Li C; Xu C; Lei Z; Zhang HT; Zhao J
    Lung Cancer; 2016 Jul; 97():87-94. PubMed ID: 27237033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FOXM1 regulated by ERK pathway mediates TGF-β1-induced EMT in NSCLC.
    Kong FF; Zhu YL; Yuan HH; Wang JY; Zhao M; Gong XD; Liu F; Zhang WY; Wang CR; Jiang B
    Oncol Res; 2014; 22(1):29-37. PubMed ID: 25700356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FOXC2 promotes epithelial-mesenchymal transition and cisplatin resistance of non-small cell lung cancer cells.
    He Y; Xie H; Yu P; Jiang S; Wei L
    Cancer Chemother Pharmacol; 2018 Dec; 82(6):1049-1059. PubMed ID: 30302523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PD-L1 expression and T cells infiltration in patients with uncommon EGFR-mutant non-small cell lung cancer and the response to immunotherapy.
    Chen K; Cheng G; Zhang F; Zhu G; Xu Y; Yu X; Huang Z; Fan Y
    Lung Cancer; 2020 Apr; 142():98-105. PubMed ID: 32120230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of cofilin‑1 and Twist‑1 protein expression in human non‑small cell lung cancer tissues.
    Chang CY; Chang SL; Leu JD; Chang YC; Hsiao M; Lin LT; Lin HN; Lee YJ
    Oncol Rep; 2019 Aug; 42(2):805-816. PubMed ID: 31233187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune Cell Composition in Human Non-small Cell Lung Cancer.
    Stankovic B; Bjørhovde HAK; Skarshaug R; Aamodt H; Frafjord A; Müller E; Hammarström C; Beraki K; Bækkevold ES; Woldbæk PR; Helland Å; Brustugun OT; Øynebråten I; Corthay A
    Front Immunol; 2018; 9():3101. PubMed ID: 30774636
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epithelial Mesenchymal Transition in Aggressive Lung Cancers.
    Mittal V
    Adv Exp Med Biol; 2016; 890():37-56. PubMed ID: 26703798
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transcription factor PREP1 induces EMT and metastasis by controlling the TGF-β-SMAD3 pathway in non-small cell lung adenocarcinoma.
    Risolino M; Mandia N; Iavarone F; Dardaei L; Longobardi E; Fernandez S; Talotta F; Bianchi F; Pisati F; Spaggiari L; Harter PN; Mittelbronn M; Schulte D; Incoronato M; Di Fiore PP; Blasi F; Verde P
    Proc Natl Acad Sci U S A; 2014 Sep; 111(36):E3775-84. PubMed ID: 25157139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
    Lu C; Shan Z; Hong J; Yang L
    Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of Human Papillomavirus Type 16 Oncoproteins Enhances Epithelial-Mesenchymal Transition via STAT3 Signaling Pathway in Non-Small Cell Lung Cancer Cells.
    Zhang W; Wu X; Hu L; Ma Y; Xiu Z; Huang B; Feng Y; Tang X
    Oncol Res; 2017 May; 25(5):843-852. PubMed ID: 28508744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nogo-B receptor promotes epithelial-mesenchymal transition in non-small cell lung cancer cells through the Ras/ERK/Snail1 pathway.
    Wu D; Zhao B; Qi X; Peng F; Fu H; Chi X; Miao QR; Shao S
    Cancer Lett; 2018 Apr; 418():135-146. PubMed ID: 29331415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. microRNA-100 functions as a tumor suppressor in non-small cell lung cancer via regulating epithelial-mesenchymal transition and Wnt/β-catenin by targeting HOXA1.
    Han W; Ren X; Yang Y; Li H; Zhao L; Lin Z
    Thorac Cancer; 2020 Jun; 11(6):1679-1688. PubMed ID: 32364673
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epithelial to mesenchymal transition is a determinant of sensitivity to chemoradiotherapy in non-small cell lung cancer.
    Shintani Y; Okimura A; Sato K; Nakagiri T; Kadota Y; Inoue M; Sawabata N; Minami M; Ikeda N; Kawahara K; Matsumoto T; Matsuura N; Ohta M; Okumura M
    Ann Thorac Surg; 2011 Nov; 92(5):1794-804; discussion 1804. PubMed ID: 22051275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PLEK2 mediates metastasis and vascular invasion via the ubiquitin-dependent degradation of SHIP2 in non-small cell lung cancer.
    Wu DM; Deng SH; Zhou J; Han R; Liu T; Zhang T; Li J; Chen JP; Xu Y
    Int J Cancer; 2020 May; 146(9):2563-2575. PubMed ID: 31498891
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Yaegashi LB; Baldavira CM; Prieto TG; Machado-Rugolo J; Velosa APP; da Silveira LKR; Assato A; Ab'Saber AM; Falzoni R; Takagaki T; Silva PL; Teodoro WR; Capelozzi VL
    Front Immunol; 2021; 12():714230. PubMed ID: 34484217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.